Sonendo Inc. in Laguna Hills raised $50 million in a growth investment round by New York private equity firm General Atlantic.
University of California-Irvine said today the National Science Foundation awarded $8 million to a UCI-led consortium to develop a system that can restore walking ability and sensation in individuals with spinal cord injuries.
Shares in Peregrine Pharmaceuticals Inc. in Tustin rose 12% in intraday trading Monday and rose another 4% after hours on a nearly four-fold increase in revenue and a sharply lower quarterly loss; trading volume on the day was three times its 90-day average. In Tuesday midday trading the drugmaker gave back some of those gains.
Santa Ana-based Johnson & Johnson Vision completed its acquisition of TearScience Inc. in Morrisville, N.C. Financial terms weren’t disclosed.
Renton, Wash.-based Providence St. Joseph Health named Erik Wexler, chief executive of the Providence Health & Services Los Angeles Region, as new head of three counties: Los Angeles, Orange and San Bernardino, effective immediately.
Allergan PLC received Korean Ministry of Food and Drug Safety approval for Belkyra, an injection that aims to reduce double chin by destroying fat cells under the chin.
Allergan PLC laid off 109 employees at its Irvine campus, according to a recent report to the state Employment Development Department.
ChromaDex. Corp. will sell its analytical testing business to Laboratory Corp. of America Holdings in Burlington, N.C.
Richard Afable, executive vice president of Providence St. Joseph Health Southern California Region, said he will retire in December.
A Los Angeles jury ordered Johnson & Johnson to pay $417 million to a 62-year-old Los Angeles woman who blamed her ovarian cancer on the company’s talc, in the first California trial over the product.
Irvine-based Sabra Health Care REIT Inc. and Care Capital Properties Inc. in Chicago announced completion of their all-stock merger despite shareholder backlash.
Sabra Health Care REIT Inc. shareholders voted to approve a proposal to issue common stock related to a pending $7.4 billion merger with Care Capital Properties Inc., a transaction scheduled to close Thursday.
University of California-Irvine researchers received more than $378 million in grants and contract funding for fiscal 2016-17, the second-highest total in campus history, UCI said.
But Company Plans To Go Forward With Deal
Irvine-based Sabra Health Care REIT Inc.’s $7.4 billion all-stock merger with Care Capital Properties Inc. in Chicago—which will create a company with a portfolio of 546 investments across 43 states and Canada—faces some headwinds after proxy advisory firm Institutional Shareholder Services Inc. recommended Sabra shareholders oppose the acquisition.
Jumpstart Companies By Various Means
Accelerators play a multifaceted role in any startups ecosystem, providing access to investors and mentors and helping companies scale.